What is Clostridioides difficile (C. diff)?
Clostridioides difficile (C. diff) is a gram-positive, spore-forming, anaerobic bacterium that causes infectious colitis through toxin production, ranging from mild diarrhea to life-threatening pseudomembranous colitis, and represents a major cause of healthcare-associated infections with significant morbidity and mortality. 1
Pathophysiology and Mechanism of Disease
C. difficile causes disease through a specific mechanism that requires two key elements:
- Acquisition of the organism (through spore transmission)
- Disruption of normal gut microbiota (typically from antibiotics)
The bacterium itself is not invasive—toxin production is the key to pathogenesis 1. Non-toxigenic strains do not cause diarrhea. The toxins (primarily toxins A and B) disrupt epithelial integrity by affecting microtubules and cell-cell tight junctions, which triggers:
- Cytokine release (particularly IL-8)
- Inflammatory infiltrate in the colonic mucosa
- Fluid shifts leading to diarrhea
- Epithelial necrosis 1
Clinical Spectrum
The manifestations vary dramatically 1:
- Asymptomatic colonization (can occur in up to 56% of treated patients for up to 6 weeks post-treatment)
- Mild-moderate diarrhea
- Severe colitis (with systemic signs)
- Fulminant disease with pseudomembranous colitis, toxic megacolon, shock, and potential death
Epidemiology and Public Health Impact
C. difficile has emerged as a significant healthcare threat, particularly since the epidemic BI/NAP1/027 strain appeared in 2000 1. The numbers are striking:
- CDI hospital discharge diagnoses more than doubled from 2001 (
148,900) to 2005 (301,200) - Incidence increased from 4.5/1000 adult discharges (2001) to 8.2/1000 (2010)
- Annual attributable costs exceed $1.5 billion in the U.S. 1
C. difficile remains an important cause of morbidity and mortality 1, and has been characterized as a new "superbug" due to its worldwide spread, limited treatment options, and high rates of recurrence and mortality 2.
Key Risk Factors
The major risk factors include 1:
- Antibiotic exposure (alters normal microbiota)
- Older age
- Recent or prolonged hospitalization
- Receipt of multiple antibiotics or longer duration of use
- Proton pump inhibitor use
- Chemotherapy
- Chronic kidney disease
- Feeding tubes
Spore Formation and Environmental Persistence
A critical feature of C. difficile is its ability to produce spores that are resistant to most standard hospital disinfectants and can survive for months in the hospital environment 3. This makes environmental contamination a persistent challenge in healthcare settings, though recent evidence suggests environmental contamination likely contributes to only 10% of new CDI cases 3.
Diagnostic Considerations
Laboratory testing alone cannot distinguish between asymptomatic colonization and symptomatic infection 1. True CDI requires both clinical symptoms (typically ≥3 unformed stools in 24 hours) AND positive laboratory testing or colonoscopic/histopathologic evidence 1.